Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 76475 

Boulevard, Bethesda, MD 20892–8401. (301) 

435–1439. lf33c.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel N43DA– 

11–5564: Developing, Validating, Refining 

Tools for Ecologic Momentary Assessment. 

Date: January 6, 2011. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Kristen V. Huntley, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 435–1433. 

huntleyk@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel 

Development of a Device for Autoadministering Naloxone to Overcome 

Overdose (2223). 

Date: January 7, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Minna Liang, PhD, 

Scientific Review Officer, Training and 

Special Projects Review Branch, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 435–1432. 

liangm@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel 

Confirming Compliance with Experimental 

Pharmacotherapy Treatment of Drug Abuse 

(2225). 

Date: January 11, 2011. 

Time: 9:30 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401. (301) 

435–1439. lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel New 

Techniques for the Large Scale Production 

and Purification of Antibodies or Vaccines 

for the Treatment of Substance Use Disorders 

(8898). 

Date: January 11, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Minna Liang, PhD, 

Scientific Review Officer, Training and 

Special Projects Review Branch, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 435–1432. 

liangm@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel Tool 

Development for New or Improved Capture 

Reagents (7779). 

Date: January 11, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Jose F. Ruiz, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 451–3086. 

ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel Realtime Activity as a Potential Diagnostic 

Marker for Pain or Drug-craving (4413). 

Date: January 12, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Scott A. Chen, PhD, 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 443–9511. 

chensc@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel 

Improving Measures of Addiction Risk 

(5562). 

Date: January 13, 2011. 

Time: 9:30 a.m. to 1:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive 

Boulevard, Bethesda, MD 20892–8401. (301) 

435–1439. lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel 

Development of a Device to Assess 

Hyperalgesia at the Bed Side by the Cold 

Pressor (2224). 

Date: January 13, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Scott A. Chen, PhD, 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401. (301) 443–9511. 

chensc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30813 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the National 

Advisory Allergy and Infectious 

Diseases Council. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council. 

Date: February 7, 2011. 

Open: 10:30 a.m. to 11:40 a.m. 

Agenda: Report from the Institute Director. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 


jlentini on DSKJ8SOYB1PROD with NOTICES
76476 Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Closed: 11:40 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Acquired Immunodeficiency Syndrome 

Subcommittee. 

Date: February 7, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room A, Bethesda, MD 20892. 

Open: 1 p.m. to adjournment. 

Agenda: Program advisory discussions and 

reports from division staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Microbiology and Infectious Diseases 

Subcommittee. 

Date: February 7, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Open: 1 p.m. to adjournment. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Allergy, Immunology and Transplantation 

Subcommittee. 

Date: February 7, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Open: 1 p.m. to adjournment. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council 

Allergy, Immunology and Transplantation 

Subcommittee. 

Date: February 7, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Open: 1 p.m. to adjournment. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Acquired Immunodeficiency Syndrome 

Subcommittee. 

Date: May 23, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room A, Bethesda, MD 20892. 

Open: 1 p.m. to adjournment. 

Agenda: Program advisory discussions and 

reports from division staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Microbiology and Infectious Diseases 

Subcommittee. 

Date: May 23, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Open: 1 p.m. to adjournment. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms F1/F2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council; 

Allergy, Immunology and Transplantation 

Subcommittee. 

Date: May 23, 2011. 

Closed: 8:30 a.m. to 10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Open: 1 p.m. to adjournment. 

Agenda: Reports from the Division Director 

and other staff. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Room D, Bethesda, MD 20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Name of Committee: National Advisory 

Allergy and Infectious Diseases Council. 

Date: May 23, 2011. 

Open: 10:30 a.m. to 11:40 a.m. 

Agenda: Report from the Institute Director. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892, 

Closed: 11:40 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, 

Conference Rooms E1/E2, Bethesda, MD 

20892. 

Contact Person: Marvin R. Kalt, PhD, 

Director, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7610, Bethesda, MD 

20892–7610, 301–496–7291, 

kaltmr@niaid.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. Information is also available on the 

Institute’s/Center’s home page: http:// 

www.niaid.nih.gov/facts/facts.htm, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices 76477 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30810 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel MBRS Score Grant Applications 

Review. 

Date: December 21, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN18, Bethesda, MD 20892. (Telephone 

Conference Call). 

Contact: Lisa Dunbar, PhD, Scientific 

Review Officer, Office of Scientific Review, 

National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, Room 3AN12, Bethesda, MD 

20892. 301–594–2849. dunbarl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30825 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

December 28, 2010, 8 a.m. to December 

29, 2010, 5 p.m., National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, 

MD 20892 which was published in the 

Federal Register on November 29, 2010, 

75 FR 73114–73115. 

The meeting will be held January 6, 

2011 to January 7, 2011. The meeting 

time and location remain the same. The 

meeting is closed to the public. 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30823 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: CIMG and GMPB. 

Date: December 21, 2010. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Patricia Greenwel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2178, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1169. greenwep@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 2, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–30821 Filed 12–7–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Auditory and Vestibular 

Neuroscience. 

Date: December 13, 2010. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


jlentini on DSKJ8SOYB1PROD with NOTICES